can i use my hsa for glp-1 medication TrimRX 16 Best Places to Get
Description
GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise

[DOI] [PubMed] [Google Scholar] 57.Blech S., Ludwig-Schwellinger E., Grfe-Mody E.U., Withopf B., Wagner K
A recent study compared semaglutide and tirzepatide for weight loss and found that tirzepatide resulted in 2.4% more weight loss at 3 months, 4.3% more at 6 months, and 6.9% more at 12 months

Gershon and Margolis, 2021)

Your provider considers how weight interacts with metabolism, menstrual cycles, and pregnancy planning when discussing treatment options
